Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Yelena Y. Janjigian | Researchclopedia

Back to researchers

Yelena Y. Janjigian

Memorial Sloan Kettering Cancer Center ORCID

716

Works

37,354

Citations

67

h-index

195

i10-index

Research Topics

Gastric Cancer Management and Outcomes Esophageal Cancer Research and Treatment Lung Cancer Treatments and Mutations

Affiliations

U.S. National Science Foundation2022–2022

Memorial Sloan Kettering Cancer Center2007–2026

The University of Texas MD Anderson Cancer Center2017–2017

Bayer (United States)2015–2015

Merck (Germany)2015–2015

Top Works

Comprehensive molecular characterization of gastric adenocarcinoma

Adam J. Bass,Natalie Tasman,et al.

20146,410 citations

Cancer Immunotherapy and Biomarkers

Cancer Genomics and Diagnostics

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

Robert Samstein,Chung‐Han Lee,et al.

20194,303 citations

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Ahmet Zehir,Ryma Benayed,et al.

20173,459 citations

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial

Yelena Y. Janjigian,Kohei Shitara,et al.

20212,789 citations

OncoKB: A Precision Oncology Knowledge Base

Debyani Chakravarty,Jianjiong Gao,et al.

20172,644 citations

<i>HER2</i> Amplification: A Potential Mechanism of Acquired Resistance to EGFR Inhibition in <i>EGFR</i> -Mutant Lung Cancers That Lack the Second-Site <i>EGFR</i> T790M Mutation

Ken Takezawa,Valentina Pirazzoli,et al.

2012722 citations

The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer

Yelena Y. Janjigian,Akihito Kawazoe,et al.

2021662 citations

CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer

Yelena Y. Janjigian,Johanna C. Bendell,et al.

2018626 citations

Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

Bastien Nguyen,Christopher J. Fong,et al.

2022618 citations